Cargando…

The demographic and treatment options for patients with large cell neuroendocrine carcinoma of the lung

INTRODUCTION: Lung large cell neuroendocrine carcinoma (L‐LCNEC) is a rare, aggressive tumor, for which the optimal treatment strategies for LCNEC have not yet been established. In order to explore how to improve the outcome of prognosis for patients with LCNEC, this study investigated the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Jianjun, Gong, Daohui, Wang, Yuxiu, Chi, Beiyuan, Zhang, Jun, Hu, Suwei, Min, Lingfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558599/ https://www.ncbi.nlm.nih.gov/pubmed/31087628 http://dx.doi.org/10.1002/cam4.2188

Ejemplares similares

AMPK α1 Downregulates ROS Levels Through Regulating Trx Leading to Dysfunction of Apoptosis in Non-Small Cell Lung Cancer
por: Gong, Daohui, et al.
Publicado: (2020)

miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer
por: Luo, Yutu, et al.
Publicado: (2022)

Treatment options for patients with large cell neuroendocrine carcinoma of the lung
por: Iyoda, Akira, et al.
Publicado: (2014)

Incidence trends of lung and gastroenteropancreatic neuroendocrine neoplasms in Switzerland
por: Alwan, Heba, et al.
Publicado: (2020)

Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung
por: Dudnik, Elizabeth, et al.
Publicado: (2021)

Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma
por: Apostolidis, Leonidas, et al.
Publicado: (2016)

Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
por: Honma, Yoshitaka, et al.
Publicado: (2019)

Age‐specific clinicopathological characteristics and prognostic analysis of neuroendocrine carcinomas of the gallbladder
por: Zhang, Zhiwei, et al.
Publicado: (2021)

Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses
por: Lin, Li‐mei, et al.
Publicado: (2020)

In‐depth molecular analysis of combined and co‐primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma
por: Hermans, Bregtje C. M., et al.
Publicado: (2021)

Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms
por: Zhang, Yu, et al.
Publicado: (2019)

Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer
por: Yan, Peng, et al.
Publicado: (2021)

Primary neuroendocrine tumors of the ovary: Management and outcomes
por: Pang, Li, et al.
Publicado: (2021)

Prediction of the World Health Organization Grade of rectal neuroendocrine tumors based on CT histogram analysis
por: Liang, Ping, et al.
Publicado: (2020)

A Comparative Study of Neuroendocrine Heterogeneity in Small Cell Lung Cancer and Neuroblastoma
por: Cai, Ling, et al.
Publicado: (2023)

Lung Large Cell Neuroendocrine Carcinoma: An Analysis of Patients from the Surveillance, Epidemiology, and End-Results (SEER) Database
por: Deng, Chong, et al.
Publicado: (2019)

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
por: Elston, Marianne S., et al.
Publicado: (2021)

Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF
por: Zhuang, Xibin, et al.
Publicado: (2019)

Incidence trend and conditional survival estimates of gastroenteropancreatic neuroendocrine tumors: A large population‐based study
por: Zhong, Qing, et al.
Publicado: (2018)

Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole‐tumor CT texture analysis as quantitative biomarkers
por: Li, Jiali, et al.
Publicado: (2018)

Coexistence of superficial carcinogenesis of resident epithelium besides neuroendocrine neoplasm of the digestive tract
por: Kuwano, Hiroyuki, et al.
Publicado: (2022)

Large-cell neuroendocrine carcinoma of the cervix
por: Yoseph, Benyam, et al.
Publicado: (2012)

Large-cell Neuroendocrine Carcinoma of the Lung with Carcinoid Syndrome
por: Yamamoto, Makoto, et al.
Publicado: (2022)

New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts
por: Lantuejoul, Sylvie, et al.
Publicado: (2020)

A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis
por: Chao, Ming, et al.
Publicado: (2016)

Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line
por: Tesfazghi, Sara, et al.
Publicado: (2013)

Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population‐based study
por: Zhang, Panpan, et al.
Publicado: (2018)

Clinicopathological features and prognosis of patients with gastric neuroendocrine tumors: A population‐based study
por: Tian, Fang‐Xi, et al.
Publicado: (2018)

Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors
por: Berardi, Rossana, et al.
Publicado: (2017)

Ovarian Large Cell Neuroendocrine Carcinoma Associated with Serous Carcinoma: Correlation of Pathology with MR Imaging
por: Takeuchi, Mayumi, et al.
Publicado: (2017)

Comprehensive molecular profiling broadens treatment options for breast cancer patients
por: Kawaji, Hitomi, et al.
Publicado: (2020)

Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis‐related genes based on the Cancer Genome Atlas
por: Dong, Ming, et al.
Publicado: (2019)

Efficacy of icotinib in advanced lung squamous cell carcinoma
por: Liang, Shuai, et al.
Publicado: (2018)

Technical Considerations in Stereotactic Ablative Radiotherapy for Localized Neuroendocrine Cancer of the Lung: Case Report and Review of the Literature
por: Callan, Laura, et al.
Publicado: (2018)

Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior
por: Morin, Emilie, et al.
Publicado: (2013)

PD‐L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer
por: Ji, Xiaoyu, et al.
Publicado: (2021)

Anti‐PD‐1 antibodies in metastatic uveal melanoma: a treatment option?
por: Bender, Carolin, et al.
Publicado: (2017)

A large, single‐center, real‐world study of clinicopathological characteristics and treatment in advanced ALK‐positive non‐small‐cell lung cancer
por: Chen, Gang, et al.
Publicado: (2017)

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
por: Meder, Lydia, et al.
Publicado: (2015)

Primary endometrial large cell neuroendocrine carcinoma with melanocytic differentiation
por: Guimarães, Lucinda Calheiros, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e5lqj5avk9t2ulsh8ka1evlcgr